Skip to content
Clinical Trials – home

Vee Perearstikeskus OÜ

Verified siteinfo

Estonia Vee Tn 6, 72713 Paide, Estonia

  • 1 trial recruiting
  • Influenza · Pneumococcal immunisation · Pneumonia respiratory syncytial viral
  • Adults and children

About Specializations

Vee Perearstikeskus OÜ in Paide, Estonia specialises in clinical trials of conditions such as Influenza, Pneumococcal immunisation, Pneumonia respiratory syncytial viral, Respiratory syncytial virus bronchiolitis, and other specialisations. This site conducts important research.

Main research areas of the site

Virus Diseases and Respiratory Tract Diseases

At Vee Perearstikeskus OÜ in Paide, Estonia, clinical research in these areas focuses on common respiratory and viral illnesses, especially influenza and respiratory syncytial virus infections. The trials are designed to assess the safety, immune response, and overall effectiveness of new vaccine candidates and related preventive approaches.

  • Studying a new influenza vaccine to see how well it protects against seasonal flu
  • Evaluating immune responses to RSV vaccination in older adults
  • Assessing the safety and tolerability of preventive vaccines for viral respiratory disease

This work supports better protection against infections that can cause significant illness in both older adults and vulnerable populations.

Bacterial Infections and Mycoses

Research in bacterial infections at this site centers on pneumococcal immunization and the prevention of disease caused by Streptococcus pneumoniae. The studies aim to compare vaccine responses, confirm protection across age groups, and further evaluate safety in infants, toddlers, children, and adolescents.

  • Testing a pneumococcal conjugate vaccine for immune protection in young children
  • Comparing vaccine performance across different age groups to support broader use
  • Monitoring safety and immune response after catch-up vaccination

These trials help advance vaccination strategies against a major bacterial cause of respiratory and invasive disease.

Virus Diseases and Bacterial Infections and Mycoses

The site also contributes to vaccine research for childhood and adolescent prevention, including varicella and pneumococcal immunization. These studies are focused on confirming that vaccine lots are consistent, safe, and capable of producing a strong immune response.

  • Evaluating a chickenpox vaccine for immune response and safety in healthy children
  • Checking consistency between vaccine manufacturing lots
  • Comparing investigational vaccines with established options to support prevention

Overall, the research supports reliable immunization programs aimed at reducing preventable infectious diseases across pediatric populations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Vee Tn 672713 PaideEstonia
Recruiting now
1 trial
Conditions studied
7
Partner status
Verified site

More sites in PaideEstonia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

6 clinical trials

Varicella

Recruiting

Study on the Immune Response and Safety of a New Varicella Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children Aged 12-15 Months

Registered drugNo placebo
Countries:EstoniaEstonia
  • Participants:0–17 years · Healthy volunteers
  • Substances:GSKVX000000025896
  • Sponsor:GlaxoSmithKline Biologicals

Study on the Safety and Immune Response of a 21-Valent Pneumococcal Vaccine in Healthy Infants, Toddlers, Children, and Adolescents

InvestigationalNo placebo
Countries:EstoniaEstonia
  • Participants:0–17 years · Healthy volunteers
  • Substances:Pneumococcal polysaccharide serotype 1
  • Sponsor:Sanofi Pasteur Inc.

Study on the Immune Response and Safety of RSVPreF3 OA Vaccine in Adults Aged 60+ with Respiratory Syncytial Virus Infections

Registered drugNo placebo
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
  • Sponsor:GlaxoSmithKline Biologicals

Influenza

Not recruiting

Study on the Safety and Immune Response of aQIVc HD Vaccine Compared to a Drug Combination for Adults 50 Years and Older at Risk of Flu Complications

Registered drugNo placebo
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:A/(H3N2)-LIKE VIRUS ANTIGEN
  • Sponsor:Seqirus UK Limited

Study on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers

Registered drugNo placebo
Countries:EstoniaEstonia
  • Participants:0–17 years · Healthy volunteers
  • Substances:Pneumococcal oligosaccharide serotype 18C conjugated to CRM197
  • Sponsor:Sanofi Pasteur Inc.

Influenza

Not recruiting

Study of mRNA-1010 Influenza Vaccine Compared to Standard Flu Vaccine in Adults 50 Years and Older

Registered drugNo placebo
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:CX-037231
  • Sponsor:Moderna Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.